目的探讨吲达帕胺致低钾血症的易患性。
Objective To investigate the liability of indapamide-induced kaliopenia.
结论月桂酰吲达帕胺为弱酸性亲脂性药物。
Conclusions Lauroyl indapamide is a weak acid with lipophilic property.
结论：所研制的吲达帕胺胶囊溶出度符合要求。
Conclusion: The dissolution of indapamide capsules are coincidence with requirement.
目的：研制吲达帕胺胶囊并对其溶出度进行考察。
Objective: To prepare indapamide capsules and evaluate its dissolution.
目的建立高效液相色谱法测定吲达帕胺缓释片含量。
Objective to establish HPLC method to determine the content of indapamide sustained release tablets.
结论吲达帕胺改善心脏功能与结构的效果优于氢氯噻嗪。
ConclusionThe effect of Indapamide on cardiac function and structure is better than Hydrochlorothiazide.
目的：对吲达帕胺片含量均匀度测定中样品的溶解方法进行改进。
Objectives: To improve the determining method of content uniformity in dissolution of indapamide tablet.
目的观察卡托普利联合吲达帕胺与单用吲达帕胺、卡托普利降压疗效及对血钾的影响。
Objective to observe the effect of serum kalium on depressurization of captopril combine with Indapamide and using them alone.
结论：研究结果为吲达帕胺(缓释片)单用或联合培哚普利用于80岁以上老年人降压治疗的临床获益提供了证据。
Conclusions The results provide evidence that antihypertensive treatment with indapamide (sustained release), with or without perindopril, in persons 80 years of age or older is beneficial.
目的：建立分离测定氨苯蝶啶、阿米洛利、呋塞米、布美他尼、氟噻嗪、吲达帕胺、苄氟噻嗪等7种利尿药的新方法。
Objective: To set up a new method for the separation of 7 diuretics: triamterene, amiloride, furosemide, bumetanide, chlorothiazide, indapamide and bendroflumethiazide.
方法：以空白丸芯、柠檬酸三乙酯、滑石粉、硬脂酸镁、胶体二氧化硅、聚维酮K30等为骨架材料制备吲达帕胺缓释胶囊；
Methods: Using eudragitrs 100, triethyl citrate, hydrated magnesium silicate, magnesium stearate, silicic acid anhydride, povidone K30 and etc as capsules preparation materials.
方法：以空白丸芯、柠檬酸三乙酯、滑石粉、硬脂酸镁、胶体二氧化硅、聚维酮K30等为骨架材料制备吲达帕胺缓释胶囊；
Methods: Using eudragitrs 100, triethyl citrate, hydrated magnesium silicate, magnesium stearate, silicic acid anhydride, povidone K30 and etc as capsules preparation materials.
应用推荐